Blocking PD-1/PD-L1 pathway by antibodies achieved clinical cure in advanced melanoma including its brain metastasis (Wolchok et al., 2017; Long et al., 2018), opening a new era of cancer therapies. The gene discussed is PDCD1; the disease is cancer.